Responsible marketing of prescription medicines is vital to maintaining consumer trust in the pharmaceutical industry and ensuring patients receive the maximum benefits from our products and services. Government regulation and industry codes oversee the marketing of our medicines, vaccines and therapies across key regions in which we operate.
CSL recognises that reputation in the marketplace and success as a trusted supplier of biopharmaceuticals relies on ensuring our medicines, vaccines and therapies are honestly represented in our interactions with healthcare professionals, consumers and other customers. Promotional Review Committees, comprising cross-functional members, operate across CSL business units to ensure compliance with all applicable local laws, regulations and accepted industry codes, such as the Medicines Australia Code of Conduct (MA Code) and the European Federation of Pharmaceutical Industries and Associations Code for European Union member countries. The committees are responsible for ensuring information on medicines, vaccines and therapy areas is balanced, supported by scientifically valid data and compliant with relevant laws and codes.
All business units, supported by complementary functions such as Medical Affairs and CSL Legal, have training programs and procedures in place to ensure compliance. When we engage with third parties, such as distributors, CSL requires these third parties to comply with all applicable laws and the principles set out in our Code. These requirements are enforced by contractual agreements and periodic reviews.